MedTrace Logo

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

NCT00131014 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-04-24

No results posted yet for this study

Summary

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Conditions

  • Non-Hodgkin's Lymphoma
  • Hodgkin's Disease
  • Leukemia, Lymphocytic, Chronic
  • Lymphoproliferative Disorders

Sponsors & Collaborators

Principal Investigators

  • Jennifer R. Brown, MD, PhD · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-09
Primary Completion
2033-01-31
Completion
2033-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131014 on ClinicalTrials.gov